Capital scale WindRose manages approximately $7 billion in capital and is actively making new investments from its seventh fund, signaling a mature fund with ongoing deployment potential for healthcare services companies at scale.

Portfolio growth Recent investments and exits (acquisitions and strategic investments in VCT, AvalonHCs, Stellus Rx, CIVIE, Altruix sale to Frazier) indicate an active M&A and bolt-on acquisition mindset, suggesting opportunities to introduce high-potential service providers or data/analytics-enabled healthcare platforms.

Technology focus Launch of WindRose Gradient to support Portfolio Company AI capabilities and adoption of AI/data analytics signals openness to technology-enabled healthcare services and platform automation opportunities.

Industry positioning Recognized as a top 20 Upper MidMarket PE firm by HEC-Dow Jones and selective focus on profitable, cost-effective healthcare services businesses offer potential for partnerships with growth-stage providers seeking strategic financing and operational improvements.

Engagement signals Active outreach and collaboration stance, including invitations for new investment conversations and healthcare executive partnerships, present openings for solution providers in healthcare services operations, data management, and regulatory/compliance tooling to align with investor interests.